Finance

Beta
Lists
688578:SHA
Shanghai Allist Pharmaceuticals Co Ltd
CNÂ¥84.29
+1.24%
(+1.03) 1D
Jun 5, 3:00:05 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688578...
Open
CNÂ¥84.50
High
CNÂ¥85.80
Low
CNÂ¥83.39
Mkt. cap
37.93B
Avg. vol.
5.29M
Volume
4.16M
Dividend
1.19%
Quarterly dividend
CNÂ¥0.25
Ex-dividend date
Jun 1, 2026
P/E ratio
15.71
52-wk high
CNÂ¥122.20
52-wk low
CNÂ¥82.97
EPS
CNÂ¥5.37
No. of employees
2K
Open
CNÂ¥84.50
High
CNÂ¥85.80
Low
CNÂ¥83.39
Mkt. cap
37.93B
Avg. vol.
5.29M
Volume
4.16M
Dividend
1.19%
Quarterly dividend
CNÂ¥0.25
Ex-dividend date
Jun 1, 2026
P/E ratio
15.71
52-wk high
CNÂ¥122.20
52-wk low
CNÂ¥82.97
EPS
CNÂ¥5.37
No. of employees
2K
News stories
From sources across the web
About Shanghai Allist Pharmaceuticals Co Ltd
CEO-
Employees1.99K
FoundedMar 22, 2004
Headquarters-
SectorPharmaceutical industry
Websiteallist.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.28B
1.36B
1.45B
1.58B
Cost of goods sold
38.59M
45.38M
44.82M
80.59M
Cost of revenue
38.59M
45.38M
44.82M
80.59M
Research and development expenses
108.84M
112.23M
100.54M
113.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
517.45M
564.71M
651.83M
646.12M
Operating expense
644.23M
695.25M
771.29M
779.22M
Total operating expenses
682.82M
740.63M
816.11M
859.80M
Operating income
592.57M
618.62M
638.21M
723.97M
Other non operating income
423.35K
-3.11M
2.18M
-4.07M
EBT including unusual items
759.70M
653.24M
656.24M
741.46M
EBT excluding unusual items
606.41M
636.19M
652.61M
742.22M
Income tax expense
118.96M
88.70M
82.91M
105.41M
Effective tax rate
15.66%
13.58%
12.63%
14.22%
Other operating expenses
17.52M
18.47M
18.97M
20.01M
Net income
640.74M
564.54M
573.33M
636.04M
Net profit margin
50.24%
41.53%
39.42%
40.16%
Earnings per share
-
-
-
-
Interest and investment income
14.61M
19.56M
17.89M
22.35M
Interest expense
-36.60K
-47.12K
-9.69K
-34.43K
Net interest expenses
14.57M
19.52M
17.88M
22.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
601.79M
627.70M
648.03M
733.79M
Gain or loss from assets sale
-21.12K
21.12K
-23.20K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer